Newsroom

YemenUne_en
Vidéos

Reportage in Haydan, Yemen, on the development of the rehabilitation care in the MSF sites.

UneBragaEN
Vidéos

Back from the field Elizabeth Braga, physiotherapist was in Jahun, Nigeria, for the MSF Foundation.

UneEN1year
Vidéos

1 year after its routine implementation, where does Antibiogo stand? Interview with Dr Nada Malou

Articles

Antibiogo: facts and impacts in the fight against antimicrobial resistance

The World Health Organization's Global AMR Awareness Week is a worldwide campaign to raise awareness and understanding of the problem of antimicrobial resistance. To mark the occasion, here is a series of infographics to help you better understand the hope that Antibiogo, a new diagnostic tool holds for combating this threat on public health.

Read more
WPC Dubai 2023 fondation msf
Vidéos

The MSF Foundation 3D program at the WPC World Physiotherapy Congress in Dubai

AI4CC qu'est-ce que c'est
Vidéos

AI4CC (Artificial intelligence for cervical cancer), what is it?

Publications

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Read more

Headline

A day at Blantyre cervical cancer referral hospital
Articles

Rehabilitation after cervical cancer treatment in Malawi: how can access for patients be improved?

In Malawi, many women treated for cervical cancer travel long distances to access rehabilitation care, even though it is essential for their recovery. In Blantyre, as part of MSF’s cervical cancer prevention and treatment programme, the MSF Foundation has been developing and supporting a specialised rehabilitation service for women for the past two years. Today, it is working to decentralise this care to make it more accessible. 

Cervical cancer remains a major public health issue in Malawi. The country has one of the highest prevalence rates in the world: nearly 40% of cancers diagnosed in women are cervical cancer, and the disease causes around 3,000 deaths every year. 

Read more

MSF Foundation in Video

News

Publications

  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.